HIV

Merck, Sangamo to Gain From $70 Million Boost in AIDS Cure Hunt
Bloomberg
Mon, 07/11/11 - 12:17 pm
AIDS
HIV
Merck
Sangamo BioSciences
grants
J&J's Been Busy
Motley Fool
Thu, 07/7/11 - 07:39 pm
JNJ
HIV
Gilead Sciences
Pharmasset
hepatitis C
Johnson & Johnson/Gilead Deal Could Yield More Combinations in HIV
Seeking Alpha
Thu, 06/30/11 - 04:30 pm
Pfizer
Merck
JNJ
HIV
GSK
Gilead Sciences
Bristol-Myers Squibb
Abbott Laboratories
Gilead, Tibotec to work on new HIV-fighting drug combos
Bizjournals.com
Tue, 06/28/11 - 11:29 pm
Tibotec
Gilead Sciences
HIV
Prezista
Emtriva
Bristol-Myers signs deal to expand HIV drug access
Yahoo/AP
Tue, 06/28/11 - 11:28 pm
HIV
Bristol-Myers Squibb
Reyataz
generics
Matrixx
AIDS Research Alliance to test GeoVax HIV vaccine
bizjournals.com
Sat, 06/25/11 - 11:57 am
GeoVax Labs
HIV
GSK HIV Drug Pipeline Sees Boost as Partner Concert Steers to Clinical Trials
Motley Fool
Tue, 06/21/11 - 10:25 am
GSK
HIV
Concert Pharmaceuticals
CTP-298
FDA approves Teva generic HIV treatment
Globes, Israel
Sun, 05/29/11 - 01:03 pm
Teva Pharmaceuticals
Combivir
HIV
Johnson & Johnson Touts Growth From New Drugs Zytiga, Edurant
Minyanville
Fri, 05/27/11 - 08:53 am
JNJ
Edurant
Zytiga
prostate cancer
HIV
AIDS
Ardea Biosciences Evenly Poised
Yahoo/Zacks.com
Wed, 05/25/11 - 09:50 am
Ardea
HIV
cancer
gout
J&J Approved, But Needs Help From a Friend
Motley Fool
Tue, 05/24/11 - 10:18 am
JNJ
HIV
Endurant
Gilead Sciences
Truvada
J&J AIDS Pill Signals $9 Billion in Revenue to Ease Recalls
Bloomberg
Mon, 05/23/11 - 11:37 am
HIV
AIDS
JNJ
Sangamo's Inevitable Acquisition/Merger
Seeking Alpha
Sun, 05/22/11 - 04:59 pm
Sangamo BioSciences
HIV
FDA approves new HIV drug from Johnson & Johnson
Yahoo/AP
Fri, 05/20/11 - 12:15 pm
HIV
FDA
JNJ
Edurant
Three Reasons That Big HIV Study May Be Less Important Than It Seems
Forbes
Sat, 05/14/11 - 12:49 pm
HIV
Novel Device Shows Promise for Reducing HIV Among Men
Thu, 05/12/11 - 07:29 pm
Novel Device
HIV
STD
Glaxo, Gilead AIDS Drugs Slash HIV Transmission by 96%
Bloomberg
Thu, 05/12/11 - 11:48 am
GSK
Gilead Sciences
AIDS
HIV
Report: GSK has no plans to sell HIV unit
Fierce Biotech
Fri, 05/6/11 - 10:04 am
HIV
M&A
GSK
ViiV Healthcare
Pfizer
Gilead AIDS prevention pill study halted; no benefit seen
Yahoo/AP
Mon, 04/18/11 - 11:01 am
Truvada
AIDS
Gilead Sciences
HIV
Abbott Agreed to Pay $52 Million to Resolve Aids Drug Case
Bloomberg
Sat, 04/16/11 - 01:28 pm
Norvir
HIV

Pages